Cargando…
Adjunctive treatment with oral AKL1, a botanical nutraceutical, in chronic obstructive pulmonary disease
PURPOSE: The objective of this pilot trial was to evaluate the safety and efficacy of AKL1, a patented botanical formulation containing extracts of Picrorhiza kurroa, Ginkgo biloba, and Zingiber officinale, as add-on therapy for patients with chronic obstructive pulmonary disease (COPD) and chronic...
Autores principales: | Brockwell, Claire, Ampikaipakan, Sundari, Sexton, Darren W, Price, David, Freeman, Daryl, Thomas, Mike, Ali, Muzammil, Wilson, Andrew M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4096458/ https://www.ncbi.nlm.nih.gov/pubmed/25031533 http://dx.doi.org/10.2147/COPD.S54276 |
Ejemplares similares
-
AKL1, a botanical mixture for the treatment of asthma: a randomised, double-blind, placebo-controlled, cross-over study
por: Thomas, Michael, et al.
Publicado: (2007) -
Emergent computation: a festschrift for Selim G. Akl
por: Adamatzky, Andrew
Publicado: (2017) -
AKL-ABC: An Automatic Approximate Bayesian Computation Approach Based on Kernel Learning
por: González-Vanegas, Wilson, et al.
Publicado: (2019) -
Adjunctive Nutraceutical Therapies for COVID-19
por: Subedi, Lalita, et al.
Publicado: (2021) -
Application of botanical products as nutraceutical feed additives for improving poultry health and production
por: El-Sabrout, Karim, et al.
Publicado: (2023)